← Open Payments lookup

ADINA BOROS: Open Payments

NPI 1194226928 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$615 in 19 payments from 9 companies in 2025. Trend: 2023 $481 · 2024 $712 · 2025 $615

Food & beverage: $503Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.3$175
Teva Pharmaceuticals USA, Inc.1$111
Alkermes, Inc.3$75
Vanda Pharmaceuticals Inc.3$69
Janssen Pharmaceuticals, Inc3$55
E.R. Squibb & Sons, L.L.C.2$40
ABBVIE INC.2$40
Otsuka America Pharmaceutical, Inc.1$29
Lundbeck LLC1$20

Products named: INGREZZA, FANAPT, INVEGA SUSTENNA, ABILIFY ASIMTUFII, ARISTADA, COBENFY, VRAYLAR, LYBALVI.

Industry payments across AZ — which companies pay providers there.